Israel - Hebräisch - Ministry of Health

rafa laboratories ltd - omeprazole 10 mg - capsules - omeprazole - acute duodenal ulcer, acute gastric ulcer, helicobacter pylori associated peptic ulcer disease in combination with antibiotics. reflux esophagitis: treatment long-term management, maintenance treatment for the prevention of relapse in patients with severe reflux esophagitis. treatment of severe reflux esophagitis in children from one year of age and older. maintenance treatment for the prevention of relapse in patients with poorly reponsive peptic ulcer. zollinger-ellison syndrome. treatment and prevention of nsaid-associated duodenal and gastric ulcer or erosions in high risk patients.

Israel - Hebräisch - Ministry of Health

rafa laboratories ltd - omeprazole - קפסולות - omeprazole 20 mg - omeprazole - omeprazole - relief of reflux-like symptoms (e.g. heartburn) with frequency of two or more days a week in sufferers aged 18 and over.

Israel - Hebräisch - Ministry of Health

takeda israel ltd - pantoprazole - טבליה - pantoprazole 40 mg - pantoprazole - pantoprazole - short term treatment of acute duodenal ulcer. acute gastric ulcer. moderate and severe reflux esophagitis. eradication of helicobacter pylori in combination with clarithromycin and amoxycillin or clarithromycin and metronidazole or amoxycillin and metronidazole in cases of duodenal ulcer and gastric ulcer with the objective of reducing of duodenal and gastric ulcers caused by this microorganism. zollinger ellison syndrome.

Israel - Hebräisch - Ministry of Health

unipharm ltd, israel - clarithromycin - טבליות מצופות - clarithromycin 250 mg - clarithromycin - clarithromycin - karin is indicated in the treatment of infections caused by one or more susceptible organisms. lower respiratory tract infections for example, acute and chronic bronchitis, and pneumonia. upper respiratory tract infections for example, sinusitis and pharyngitis. karin is also indicated in skin and soft tissue infections of mild to moderate severity. karin is also indicated in combination with proton pump inhibitor for the eradication of h.pylori in patients with proven duodenal ulcers.

Israel - Hebräisch - Ministry of Health

unipharm ltd, israel - clarithromycin - טבליות מצופות - clarithromycin 500 mg - clarithromycin - clarithromycin - karin is indicated in the treatment of infections caused by one or more susceptible organisms. lower respiratory tract infections for example, acute and chronic bronchitis, and pneumonia. upper respiratory tract infections for example, sinusitis and pharyngitis. karin is also indicated in skin and soft tissue infections of mild to moderate severity.karin is also indicated in combination with proton pump inhibitor for the eradication of h.pylori in patients with proven duodenal ulcers. treatment of mycobacterium avium complex infection in aids patients

Israel - Hebräisch - Ministry of Health

dexcel ltd, israel - clarithromycin - קפליות - clarithromycin 250 mg - clarithromycin - clarithromycin - klaridex is indicated in the treatment of infections caused by one or more susceptible organisms. indications include: lower respiratory tract infections, for example, acute and chronic bronchitis and pneumonia. upper respiratory tract infections, for example, sinusitis and pharyngitis. klaridex is appropriate for initial therapy in community acquired respiratory infections and has been shown to be active in vitro against common and atypical respiratory pathogens as listed in the microbiology section. klaridex is also indicated in skin and soft tissue infections of mild to moderate severity. klaridex is also indicated in combination with proton pump inhibitor for the eradication of h. pylori in patients with proven duodenal ulcer. treatment of mycobacterium avium complex infection in aids patients.

Israel - Hebräisch - Ministry of Health

taro international ltd - lansoprazole 15 mg - capsules - proton pump inhibitors - for the treatment of duodenal ulcer, benign gastric ulcer, reflux oesophagitis and acid related disorders of the upper gastrointestinal tract. healing, long term treatment and maintenance therapy for patients with gastro oesophageal reflux disease (gord) or duodenal ulcer. prevention of relapse in patients with gord or duodenal ulcer. eradication of h. pylori from the upper gastrointestinal tract in patients with duodenal ulcer, gastritis or benign ulcer (in combination with appropriate antibiotics). short term treatment (up to four weeks) of heartburn and/or upper epigastric pain associated with acid-related dyspepsia. long-term management of pathological hypersecretory conditions including zollinger ellison syndrome.treatment and prophylaxis of nsaid- associated benign gastric ulcers, duodenal ulcers and relief of symptoms in patients requiring continued nsaid treatment.

Israel - Hebräisch - Ministry of Health

taro international ltd - lansoprazole 30 mg - capsules - proton pump inhibitors - for the treatment of duodenal ulcer, benign gastric ulcer, reflux oesophagitis and acid related disorders of the upper gastrointestinal tract. healing, long term treatment and maintenance therapy for patients with gastro oesophageal reflux disease (gord) or duodenal ulcer. prevention of relapse in patients with gord or duodenal ulcer. eradication of h. pylori from the upper gastrointestinal tract in patients with duodenal ulcer, gastritis or benign ulcer (in combination with appropriate antibiotics). short term treatment (up to four weeks) of heartburn and/or upper epigastric pain associated with acid-related dyspepsia. long-term management of pathological hypersecretory conditions including zollinger ellison syndrome. treatment and prophylaxis of nsaid- associated benign gastric ulcers, duodenal ulcers and relief of symptoms in patients requiring continued nsaid treatment.

Israel - Hebräisch - Ministry of Health

novartis israel ltd - lapatinib as ditosylate monohydrate - טבליות מצופות פילם - lapatinib as ditosylate monohydrate 250 mg - protein kinase inhibitors - tykerb is indicated for the treatment of adult patients with breast cancer, whose tumours overexpress her2 (erbb2);• in combination with capecitabine for patients with advanced or metastatic disease with progression following prior therapy, which must have included anthracyclines and taxanes and therapy with trastuzumab in the metastatic setting (see section 5.1).• tykerb is indicated in combination with letrozole for the treatment of postmenopausal women with hormone receptor positive metastatic breast cancer that overexpresses the her2 receptor for whom hormonal therapy is indicated. tykerb in combination with an aromatase inhibitor has not been compared to a trastuzumab-containing chemotherapy regimen for the treatment of metastatic breast cancer.

Israel - Hebräisch - Ministry of Health

rafa laboratories ltd - omeprazole - קפסולות - omeprazole 40 mg - omeprazole